6578 達邦蛋白本益比(PER)
| 年度/月份 | 本益比(倍) | 月收盤價 |
|---|
| 2026/05 | -76.25 | 15.25 |
| 2026/04 | -76.75 | 15.35 |
| 2026/03 | -88.00 | 17.60 |
| 2026/02 | -94.75 | 18.95 |
| 2026/01 | -100.25 | 20.05 |
| 2025/12 | -95.50 | 19.10 |
| 2025/11 | -97.75 | 19.55 |
| 2025/10 | -100.50 | 20.10 |
| 2025/09 | -105.00 | 21.00 |
| 2025/08 | -120.00 | 24.00 |
| 2025/07 | 255.56 | 23.00 |
| 2025/06 | 206.11 | 18.55 |
| 2025/05 | 191.11 | 17.20 |
| 2025/04 | 100.59 | 17.10 |
| 2025/03 | 108.82 | 18.50 |
| 2025/02 | 111.47 | 18.95 |
| 2025/01 | 136.92 | 17.80 |
| 2024/12 | 152.31 | 19.80 |
| 2024/11 | 146.92 | 19.10 |
| 2024/10 | -53.78 | 19.90 |
| 2024/09 | -61.35 | 22.70 |
| 2024/08 | -62.84 | 23.25 |
| 2024/07 | -37.90 | 23.50 |
| 2024/06 | -45.73 | 28.35 |
| 2024/05 | -45.08 | 27.95 |
| 2024/04 | -25.79 | 27.60 |
| 2024/03 | -23.64 | 25.30 |
| 2024/02 | -22.57 | 24.15 |
| 2024/01 | -15.49 | 20.75 |
| 2023/12 | -15.63 | 20.95 |
| 2023/11 | -15.49 | 20.75 |
| 2023/10 | -17.04 | 16.70 |
| 2023/09 | -17.50 | 17.15 |
| 2023/08 | -16.94 | 16.60 |
| 2023/07 | -14.34 | 17.35 |
| 2023/06 | -15.45 | 18.70 |
| 2023/05 | -14.92 | 18.05 |
| 2023/04 | -16.00 | 18.40 |
| 2023/03 | -15.09 | 17.35 |
| 2023/02 | -14.04 | 16.15 |
| 2023/01 | -12.90 | 16.00 |
| 2022/12 | -12.98 | 16.10 |
| 2022/11 | -12.70 | 15.75 |
| 2022/10 | -10.62 | 14.65 |
| 2022/09 | -10.14 | 14.00 |
| 2022/08 | -12.39 | 17.10 |
| 2022/07 | -13.40 | 17.15 |
| 2022/06 | -13.75 | 17.60 |
| 2022/05 | -18.01 | 23.05 |
| 2022/04 | -11.12 | 21.35 |
| 2022/03 | -8.67 | 16.65 |
| 2022/02 | -8.72 | 16.75 |
| 2022/01 | -11.07 | 16.60 |
| 2021/12 | -11.63 | 17.45 |
| 2021/11 | -12.53 | 18.80 |
| 2021/10 | -18.94 | 17.05 |
| 2021/09 | -19.61 | 17.65 |
| 2021/08 | -19.11 | 17.20 |
| 2021/07 | -41.35 | 19.85 |
| 2021/06 | -42.40 | 20.35 |
| 2021/05 | -42.08 | 20.20 |
| 2021/04 | 94.79 | 22.75 |
| 2021/03 | 92.50 | 22.20 |
| 2021/02 | 89.17 | 21.40 |
| 2021/01 | - | 20.80 |